Patient
|
Age/Gender
|
Type of Cancer
|
Previous therapy
|
Ongoing treatment
|
Analgesic score (Type)
|
Analgesic score (quantity)
|
1
|
51/M
|
mCRPC
|
First and second generation anti-androgens, chemotherapy
|
Androgen synthesis inhibitor
|
Morphine
|
2
|
2
|
25/F
|
Non-small cell right lung cancer
|
Lobectomy, chemotherapy, radiotherapy
|
-
|
Morphine
|
2
|
3
|
60/M
|
Right breast cancer
|
Chemotherapy, radiotherapy
|
-
|
Morphine
|
2
|
4
|
44/F
|
B/L breast cancer
|
B/L breast mastectomy, chemotherapy, radiotherapy, monoclonal antibody therapy
|
-
|
Morphine
|
2
|
5
|
61/M
|
Right breast cancer
|
Hormonal therapy, Chemotherapy, radiotherapy
|
-
|
Atypical opioids and non-morphine opioids
|
3
|
6
|
70/M
|
mCRPC
|
Medical castrartion, First-generation anti-androgen therapy, chemotherapy, radiotherapy
|
Second-generation anti-androgens
|
Morphine
|
4
|
7
|
63/M
|
mCRPC
|
B/L orchidectomy, first-generation anti-androgens, chemotherapy, radiotherapy
|
-
|
Atypical opioids and non-morphine opioids
|
2
|
8
|
60/F
|
Small-cell lung cancer
|
Chemotherapy, radiotherapy
|
-
|
Atypical opioids and non-morphine opioids
|
3
|
9
|
44/F
|
Right breast cancer
|
Right breast mastectomy, hormonal therapy, chemotherapy, radiotherapy
|
-
|
Atypical opioids and non-morphine opioids
|
2
|
10
|
65/F
|
Left breast cancer
|
Hormonal therapy, chemotherapy,
|
-
|
Atypical opioids and non-morphine opioids
|
2
|
11
|
33/F
|
Right breast cancer
|
Chemotherapy, radiotherapy
|
-
|
Morphine
|
2
|
12
|
74/M
|
mCRPC
|
Radical Prostatectomy, B/L orchidectomy, first-generation anti-androgens, chemotherapy,
|
-
|
Atypical opioids and non-morphine opioids
|
2
|
13
|
45/F
|
Left breast cancer
|
Left breast modified radical mastectomy, hormonal therapy, chemotherapy, radiotherapy,
|
-
|
Atypical opioids and non-morphine opioids
|
3
|
14
|
27/F
|
B/L breast cancer
|
Hormonal therapy, B/L mastectomy, chemotherapy, radiotherapy,
|
-
|
Morphine
|
2
|
15
|
47/F
|
Left breast cancer
|
Hormonal therapy, chemotherapy, radiotherapy, antibody therapy
|
-
|
Other NSAIDs
|
1
|
16
|
27/F
|
Left breast cancer
|
chemotherapy, radiotherapy,
|
-
|
Other NSAIDs
|
2
|
17
|
55/M
|
mCRPC
|
B/L orchidectomy,
First and second generation anti-androgens, chemotherapy, radiotherapy
|
Androgen synthesis inhibitors
|
Other NSAIDs
|
3
|
18
|
44/F
|
Left breast cancer
|
Left modified radical mastectomy, chemotherapy, radiotherapy
|
-
|
Morphine
|
2
|
19
|
58/F
|
Right breast cancer
|
Rt breast mastectomy chemotherapy, radiotherapy
|
-
|
Atypical opioids and non-morphine opioids
|
4
|
20
|
24/M
|
Sqaumous cell cancer of lung
|
Surgery, chemotherapy
|
-
|
Morphine
|
2
|
21
|
55/F
|
Left breast cancer
|
Surgery, chemotherapy, radiotherapy
|
-
|
Atypical opioids and non-morphine opioids
|
2
|
22
|
55/F
|
Sqaumous cell cancer of lung
|
Chemotherapy, radiotherapy
|
-
|
Atypical opioids and non-morphine opioids
|
2
|
23
|
54/F
|
Right breast cancer
|
Chemotherapy, radiotherapy
|
-
|
Atypical opioids and non-morphine opioids
|
3
|
24
|
40/F
|
Right breast cancer
|
Chemotherapy, radiotherapy
|
-
|
Morphine
|
2
|
25
|
54/M
|
mCRPC
|
Medical castration, Chemotherapy, radiotherapy
|
Androgen-synthesis inhibitors
|
Morphine
|
2
|
26
|
63/F
|
B/L breast cancer
|
Bilateral mastectomy, chemotherapy, radiotherapy
|
-
|
Atypical opioids and non-morphine opioids
|
2
|
27
|
47/F
|
Right breast cancer
|
Right breast mastectomy, hormonal therapy, chemotherapy, radiotherapy
|
-
|
Morphine
|
2
|
28
|
50/M
|
Right breast cancer
|
Right modified radical mastectomy, Chemotherapy, radiotherapy
|
-
|
Morphine
|
2
|
29
|
40/F
|
B/L breast cancer
|
Hormonal therapy, Chemotherapy, radiotherapy
|
-
|
Morphine
|
2
|
30
|
75/M
|
mCRPC
|
B/L orchidectomy, chemotherapy,
First and second generation anti-androgens, radiotherapy
|
None
|
Atypical opioids and non-morphine opioids
|
2
|
31
|
67/M
|
mCRPC
|
B/L orchidectomy, first-generation anti-androgens
Chemotherapy, radiotherapy,
|
Second-generation anti-androgens
|
Atypical opioids and non-morphine opioids
|
2
|
32
|
78/M
|
mCRPC
|
B/L orchidectomy,
Chemotherapy,
|
androgen synthesis inhibitor
|
Atypical opioids and non-morphine opioids
|
2
|
33
|
48/F
|
B/L breast cancer
|
Chemotherapy, radiotherapy
|
-
|
Atypical opioids and non-morphine opioids
|
2
|
34
|
40
|
Right breast cancer
|
Right modified radical mastectomy, chemotherapy, radiotherapy
|
-
|
Atypical opioids and non-morphine opioids
|
2
|
35
|
70/M
|
mCRPC
|
Medical castration,
chemotherapy, radiotherapy
|
Androgen-synthesis inhibitors
|
Morphine
|
2
|
36
|
43/M
|
Non -small cell lung cancer of the right lung
|
Chemotherapy, radiotherapy
|
-
|
Atypical opioids and non-morphine opioids
|
2
|
37
|
32/F
|
Right breast cancer
|
Right breast mastectomy Chemotherapy, radiotherapy
|
-
|
Atypical opioids and non-morphine opioids
|
2
|
38
|
67/F
|
Right breast cancer
|
Right modified radical mastectomy, hormonal therapy chemotherapy, radiotherapy
|
-
|
Atypical opioids and non-morphine opioids
|
2
|
39
|
30/F
|
Small cell cancer of lung
|
Chemotherapy, radiotherapy
|
-
|
Atypical opioids and non-morphine opioids
|
3
|
40
|
76/M
|
mCRPC
|
B/L orchidectomy, First-generation anti-androgens, chemotherapy, radiotherapy
|
Second-generation anti-androgens
|
Atypical opioids and non-morphine opioids
|
2
|